Hahné Susan J M, Nic Lochlainn Laura M, van Burgel Nathalie D, Kerkhof Jeroen, Sane Jussi, Yap Kioe Bing, van Binnendijk Rob S
Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven.
European Programme for Intervention Epidemiology Training, European Centre for Disease Prevention and Control, Stockholm, Sweden.
J Infect Dis. 2016 Dec 15;214(12):1980-1986. doi: 10.1093/infdis/jiw480. Epub 2016 Oct 7.
We investigated a measles outbreak among healthcare workers (HCWs) by assessing laboratory characteristics, measles vaccine effectiveness, and serological correlates for protection.
Cases were laboratory-confirmed measles in HCWs from hospital X during weeks 12-20 of 2014. We assessed cases' severity and infectiousness by using a questionnaire. We tested cases' sera for measles immunoglobulin M, immunoglobulin G, avidity, and plaque reduction neutralization (PRN). Throat swabs and oral fluid samples were tested by quantitative polymerase chain reaction. We calculated attack rates (ARs) by vaccination status and estimated measles vaccine effectiveness as 1 - [AR/AR].
Eight HCWs were notified as measles cases; 6 were vaccinated with measles vaccine twice, 1 was vaccinated once, and 1 was unvaccinated. All 6 twice-vaccinated cases had high avidity and PRN titers. None reported severe measles or onward transmission. Two of 4 investigated twice-vaccinated cases had pre-illness PRN titers of >120 mIU/mL. Among 106 potentially exposed HCWs, the estimated effectiveness of 2 doses of measles vaccine was 52% (95% confidence interval [CI], -207%-93%).
Measles occurred in 6 twice-vaccinated HCWs, despite 2 having adequate pre-exposure neutralizing antibodies. None of the twice-vaccinated cases had severe measles, and none had onward transmission, consistent with laboratory findings suggesting a secondary immune response. Improving 2-dose MMR coverage among HCWs would have likely reduced the size of this outbreak.
我们通过评估实验室特征、麻疹疫苗效力以及保护的血清学相关因素,对医护人员中的麻疹暴发情况进行了调查。
病例为2014年第12 - 20周期间来自X医院的实验室确诊麻疹医护人员。我们通过问卷调查评估病例的严重程度和传染性。我们检测病例血清中的麻疹免疫球蛋白M、免疫球蛋白G、亲和力以及空斑减少中和试验(PRN)。通过定量聚合酶链反应检测咽拭子和口腔液样本。我们按疫苗接种状态计算罹患率(ARs),并将麻疹疫苗效力估计为1 - [AR/AR]。
8名医护人员被通报为麻疹病例;6人接种过两次麻疹疫苗,1人接种过一次,1人未接种。所有6名接种过两次疫苗的病例均有高亲和力和PRN滴度。无人报告患重症麻疹或出现传播。4名接受调查的接种过两次疫苗的病例中有2人发病前PRN滴度>120 mIU/mL。在106名可能暴露的医护人员中,两剂麻疹疫苗的估计效力为52%(95%置信区间[CI],-207% - 93%)。
6名接种过两次疫苗的医护人员发生了麻疹,尽管其中2人在暴露前有足够的中和抗体。接种过两次疫苗的病例中无人患重症麻疹,也无人出现传播,这与实验室结果提示的二次免疫反应一致。提高医护人员两剂次麻腮风疫苗的接种覆盖率可能会减少此次暴发的规模。